Roger Andersen

Roger manages Ondine’s regulatory and clinical programs, working extensively with the FDA, Health Canada, and the EU to obtain regulatory approvals. Prior to joining the company, he practiced as a physician and surgeon in Seattle and directed a clinical research organization for pharmaceutical and medical device clinical trials.